Prevention of experimental allergic encephalomyelitis via inhibition of IL-12-mediated Th1 differentiation: An effect of the novel anti-inflammatory drug lisofylline

Journal of Immunology

Volumn 161, Issue 12, 1998, Pages 7015-7022

  Bright, John J ^a   Du, Caigan ^a   Coon, Michael ^b   Sriram, Subramaniam ^a   Klaus, Stephen J ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Cell Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; LISOFYLLINE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANTIBODY RESPONSE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL MEDIATED CYTOTOXICITY; CELL SURVIVAL; DEMYELINATION; DRUG EFFECT; DRUG MECHANISM; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADOPTIVE TRANSFER; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; DRUG EVALUATION, PRECLINICAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION REGULATION; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; MYELIN BASIC PROTEINS; PENTOXIFYLLINE; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TH1 CELLS;

EID: 0032534750     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Owens, T., and S. Sriram. 1995. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol. Clin. 13:51.
2. Merrill, J. E., D. H. Kono, J. Clayton, D. G. Ando, D. R. Hinton, and F. M. Hofman. 1992. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA 89:574.
3. Windhagen, A., J. Newcombe, F. Dangond, C. Strand, M. N. Woodroofe, M. L. Cuzner, and D. A. Hafler. 1995. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokines in multiple sclerosis lesions. J. Exp. Med. 182:1985.
4. Hofman, F. M., D. R. Hinton, K. Johnson, and J. E. Merrill. 1989. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170:607.
5. Leonard, J. P., K. E. Waldburger, and S. J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381.
6. Selmaj, K., C. S. Raine, and A. H. Cross. 1991. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30:694.
7. Ruddle, N. H., C. M. Bergman, K. M. McGrath, E. G. Lingenheld, M. L. Grunnet, S. J. Padula, and R. B. Clark. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1193.
8. Khoury, S. J., W. W. Hancock, and H. L. Weiner. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1355.
9. Shaw, M. K., J. B. Lorens, A. Dhawan, R. DalCanto, H. Y. tse, A. B. Tran, C. Bonpane, S. L. Eswaran, S. Brocke, N. Sarvetnick, L. Steinman, G. P. Nolan, and C. G. Fathman. 1997. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1711.
10. Racke, M. K., S. Sriram, J. Carlino, B. Cannella, C. S. Raine, and D. E. McFarlin. 1993. Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor β2. J. Neuroimmunol. 46:175.
11. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
12. + T cells to enhance priming for interferon γ production and diminished interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
13. Thierfelder, W. E., J. M. van Deursen, K. Yamamoto, R. A. Tripp, S. R. Sarawar, R. T. Carson, M. Y. Sangster, D. A. A. Vignali, P. C. Doherty, G. C. Grosveld, and J. N. Ihle. 1996. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171.
14. Kaplan, M. H., Y. Sun, T. Hoey, and M. J. Grusby. 1996. Impaired 1L-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174.
15. Trembleau, S., G. Penna, E. Bosi, A. Mortara, M. K. Gately, and L. Adorini. 1995. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817.
16. Neurath, M. F., I. Fuss, B. L. Kelsall, E. Stuber, and W. Strober. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1281.
17. Williamson, E., P. Garside, J. A. Bradley, I. A. R. More, and A. M. Mowat. 1997. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarized the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease. J. Immunol. 159:1208.
18. Abraham, E., S. Bursten, R. Shenkar, J. Allbee, R. Tuder, P. Woodson, D. M. Guidot, G. C. Rice, J. W. Singer, and J. E. Repine. 1995. Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice. J. Exp. Med. 181:569.
19. de Vries, P., J. Xu, and J. W. Singer. 1997. Lisofylline abrogates the cytotoxic drug-induced ex vivo release of hematopoietic inhibitors by murine spleen cells. Exp. Hematol. 25:837.
20. Hasegawa, N., Y. Oka, M. Nakayama, G. J. Gerry, S. Bursten, G. C. Rice, and T. Raffin. 1997. The effects of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced acute lung injury in pigs. Am. J. Respir. Crit. Care Med. 155:928.
21. List, A., R. Maziarz, P. Stiff, J. Jansen, J. Liesfeld, M. Schuster, D. F. Andrews, I. Karanes, S. Wolf, and M. Litzow. 1996. Lisofylline reduces infection rate and improves survival in pts undergoing allogeneic bone marrow transplantation: result of a randomized, placebo-controlled trial. Blood 88:459.
22. Singer, J. W., A. List, D. Federighi, T. Michnick, and S. Bursten. 1996. Serum hydroperoxy and hydroxyoctadecadienoic acids (HPODE and HODE) increase in response to total body irradiation and are suppressed by lisofylline (LSF) in allogeneic BMT patients. Blood 88:458.
23. Camacho, M., N. Godessart, R. Anton, M. Garcia, and L. Vila. 1995. Interleukin-1 enhances the ability of cultured human umbilical vein endothelial cells to oxidize linoleic acid. J. Biol. Chem. 270:17279.
24. Khan, B. V., S. S. Parthasarathy, R. W. Alexander, and R. M. Medford. 1995. Modified low density lipoprotein and its constituents augment cytokine activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest. 95:1262.
25. Iwamoto, K. S., and W. H. McBride. 1994. Production of 13-Hydroxyoctadecadienoic acid and tumor necrosis factor α by murine peritoneal macrophages in response to irradiation. Radiat. Res. 139:103.
26. LeGros, G., S. Z. Ben-Sasson, R. Seder, F. D. Finkelman, and W. E. Paul. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172:921.
27. Rott, O., C. Evelyne, and B. Fleischer. 1993. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1-but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur. J. Immunol. 23:1745.
28. Moller, D. R., M. Wysocka, B. M. Greenlee, X. Ma, L. Wahl, G. Trinchier, and C. L. Karp. 1997. Inhibition of human interleukin-12 production by pentoxifylline. Immunology 91:197.
29. Bright, J. J., B. F. Musuro, C. Du, and S. Sriram. 1998. Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis. J. Neuroimmunol. 82:22.
30. Segal, B. M., B. K. Dwyer, and E. M. Shevach. 1998. An interleukin (IL)-10/ IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187:537.
31. Simmons, R. D., and D. O. Willenborg. 1990. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J. Neurol. Sci. 100:37.
32. Panitch, H. S., and C. T. Bever. 1993. Clinical trials of interferons in multiple sclerosis. J. Neuroimmunol. 46:155.
33. Ferber, I. A., S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C. G. Fathman. 1996. Mice with a disrupted IFN γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:5.
34. Billiau, A., H. Heremans, F. Vandekerckhove, R. Dijkmans, H. Sobis, E. Meulepas, and H. Carton. 1988. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN γ. J. Immunol. 140:1506.
35. Duong, T. T., J. St. Louis, J. J. Gilbert, F. D. Finkelman, and G. H. Strejan. 1992. Effect of anti-interferon γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 36:105.
36. Heremans, H., C. Dillen, R. Dijkmans, G. Grau, and A. Billiau. 1989. The role of cytokines in various animal models of inflammation. Lymphokine Res. 8:329.
37. Horwitz, M. S., C. F. Evans, D. B, McGavern, M. Rodriguez, and M. B. A. Oldstone. 1997. Primary demyelination in transgenic mice expressing interferon-γ. Nat. Med. 3:1037.
38. Male, D., G. Pryce, C. Hughes, and P. Lantos. 1990. Lymphocyte migration into brain modelled in vitro: control by lymphocyte activation, cytokines, and antigen. Cell. Immunol. 127:1.
39. Sethna, M. P., and L. A. Lampson. 1991. Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-γ. J. Neuroimmunol. 34:121.
40. Fierz, W., B. Endler, K. Reske, H. Wekerle, and A. Fontana. 1985. Astrocytes as antigen-presenting cells: induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J. Immunol. 134:3785.
41. McCarron, R. M., M. Spatz, O. Kempski, R. N. Hogan, L. Muehl, and D. E. McFarlin. 1986. Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells. J. Immunol. 137:3428.
42. Basham, T. Y., and T. C. Merigan. 1982. Recombinant interferon-γ increases HLA-DR synthesis and expression. J. Immunol. 130:1492.
43. Sztein, M. B., P. S. Steeg, H. M. Johnson, and J. J. Oppenhim. 1984. Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J. Clin. Invest. 73:556.
44. Ding, A., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141:2407.
45. Cross, A. H., R. M. Keeling, S. Goorha, M. San, C. Rodi, P. S. Wyatt, P. T. Manning, and T. Misko. 1996. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 71:145.
46. Hooper, D. C., O. Baasra, J. C. Marini, A. Zborek, S. T. Ohnishi, R. Kean, J. M. Champion, A. B. Sarker, L. Bobroski, J. L. Farber, Akaike, H. Maeda, and H. Koprowski. 1997. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA 94:2528.
47. Toshniwal, P. K., and E. J. Zarling. 1992. Evidence for increased lipid peroxidation in multiple sclerosis. Neurochem. Res. 17:205.
48. Naidoo, R., and M. L. Knapp. 1992. Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions. Clin. Chem. 38:2449.
49. Friedmann, M. C., T. S. Migone, S. M. Russell, and W. J. Leonard. 1996. Different interleukin 2 receptor β-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc. Natl. Acad. Sci. USA 5:2077.
50. Nakajima, H., X. W. Liu, A. Wynshaw-Boris, L. A. Rosenthal, K. Imada, D. S. Finbloom, L. Hennighausen, and W. J. Leonard. 1997. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor α chain induction. Immunity 7:691.
51. Shimoda, K., J. vanDeursen, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. Vignali, P. C. Doherty, G. Grosveld, W. E. Paul, and J. N. Ihle. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630.
52. Stockschlader, M., P. Kalhs, S. Peters, W. Zeller, W. Kruger, H. Kabisch, K. Lechner, and A. Zander. 1993. Intravenous pentoxifylline failed to prevent transplant-related toxicities in allogeneic bone marrow transplant recipients. Bone Marrow Transplant. 12:357.
53. Clift, R. A., J. A. Bianco, F. R. Appelbaum, C. D. Buckner, J. W. Singer, L. Bakke, W. I. Bensinger, R. A. Bowden, G. B. McDonald, M. Schubert, et al. 1993. A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicites in patients undergoing allogeneic marrow transplantation. Blood 82:2025.
54. Attal, M., F. Huguet, H. Rubie, J. P. Charlet, D. Schlaifer, A. Huynh, G. Laurent, and J. Pris. 1993. Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial. Blood 82:732.
55. van Oosten, B. W., M. H. G. Rep, R. A. W. van Lier, P. E. T. Scholten, B. M. E. von Blomberg, K. W. Pflughaupt, H. P. Hartung, H. J. Ader, and C. H. Polman. 1996. A pilot study investigating the effects of orally administered pentoxifylline on selected immune variables in patients with multiple sclerosis. J. Neuroimmunol. 66:49.
56. Lu, C., M. A. Jensen, and B. G. W. Arnason. 1993. Interferon-γ-and interleukin-4-secreting cells in multiple sclerosis. J. Neuroimmunol. 46:123.
57. Olssen, T., W. W. Zhi, B. Höjeberg, V. Kostulas, J. Yu-Ping, G. Anderson, H. Ekre, and H. Link. 1990. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ. J. Clin. Invest. 86:981.